Biotech, healthtech and medtech researchers in Utrecht take this part-time validation track over eight months, at one to two half-days a month. UtrechtInc offers no investment and the programme is free for Utrecht researchers and scientists; it takes no equity, though a success fee applies only if revenue exceeds EUR 150k in years three to five.
Investment
Not disclosed
Equity taken
0% (Like 88% of Europe & C. Asia · Like 79% globally)
Duration
35 weeks (Longer than Europe & C. Asia median 26 wks · Longer than global median 20 wks)